023-906-714-658-02X
Abstract
The invention provides antibodies that specifically bind transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, among other applications.
Claims
Download PDF
Document Preview
Document History
- Publication: Feb 15, 2018
-
Application:
Jun 30, 2017
-
Priority:
Jul 2, 2016
